The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Hy-Tape International sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
HTL-STREFA SA (HTL- STREFA), a subsidiary of Medical Technology and Devices SpA, is a manufacturer and exporter of medical devices. The company’s products portfolio includes safety lancets, pen needles, safety pen needles, personal lancets, blood lancets and lancing device. It also offers products related to covid-19. HTL- STREFA markets its products under the brands Medlance, DROPLET, HAEMOFINE and HTL- STREFA. The company products are used in various diagnostic tests performed by hospitals, clinics, and laboratories. It operates in production facilities and sales and marketing offices in the US and Poland. HTL- STREFA is headquartered in Ozorkow, Poland.
The key metrics of Hy-Tape International related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Hy-Tape International is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Hy-Tape International.
For a detailed understanding of the performance of Hy-Tape International, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
